Top Markets
#1 Islamic Coin Islamic Coin +151.51%
#2 Akedo Akedo +55.89%
#3 DOVU DOVU +48.37%
#4 Velvet Velvet +44.60%
#5 Black Phoenix Black Phoenix +34.05%
#6 Cross Cross +27.56%
#7 Cap Cap +19.95%
#8 DoubleZero DoubleZero +17.42%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +9.92%
#10 Pieverse Pieverse +9.84%
Coin of the day
Islamic Coin Islamic Coin
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
C4X Discovery Holdings plc C4X Discovery Holdings plc

C4X Discovery Holdings plc

C4XD
Rang in Aktien #39623
C4X Discovery Holdings plc is a pharmaceutical research firm based in... C4X Discovery Holdings plc is a pharmaceutical research firm based in Manchester, United Kingdom, specializing in the discovery of new drugs. The company leverages advanced proprietary technologies for drug discovery, including Taxonomy3, an innovative computational platform employing unique mathematical algorithms to conduct intricate multi-variable analysis of genetic information. Additionally, Conformetrix provides a technology to precisely determine the three-dimensional structures of unbound drug molecules using experimental data, furnishing medicinal chemists with unparalleled understanding of their physical characteristics and how they behave. Its 4Sight tool further enables the visualization of four-dimensional molecules within a virtual reality environment. The company's development pipeline features several promising candidates: an Orexin-1 receptor antagonist aimed at addictive disorders; an NRF-2 activator targeting various inflammatory conditions; an IL-17A inhibitor for inflammation and autoimmune responses; α4β7 integrin inhibitors developed for inflammatory bowel disease; and MALT-1 inhibitors designed to combat hematological cancers. C4X Discovery has established significant collaborations with key industry players such as Sanofi, GEN-COVID, LifeArc, Indivior PLC, Phoremost, AstraZeneca UK Limited, and Evotec SE. Established in 2007, the company initially traded as Schosween 24 plc before adopting its current name, C4X Discovery Holdings plc, in October 2014.
Aktienkurs
$0.16328419
Zuletzt synchronisiert: 2024-04-25
Marktkapitalisierung
$411.85K
Veränderung (1 Tag)
38.98%
Veränderung (1 Jahr)
0.00%
Land
GB
Handel C4X Discovery Holdings plc (C4XD)

Kategorie

Healthcare
Operative Marge für C4X Discovery Holdings plc (C4XD)
Operative Marge zum 2026 TTM: 0.00%
Laut den neuesten Finanzberichten und dem Aktienkurs von C4X Discovery Holdings plc beträgt die aktuelle operative Marge (TTM) 0.00%. Am Ende des Jahres 2026 lag die operative Marge bei 0.00%.
Historie der operativen Marge von C4X Discovery Holdings plc von 2026 bis 2026
Operative Marge zum Jahresende
Jahr Operative Marge ändert
Nicht genügend Daten für die angegebenen Daten.
Operative Marge vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Operative Marge Differenz der operativen Marge Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.97% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
0.00% -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
31.23% -
BE
Was ist die operative Marge eines Unternehmens?
Die operative Marge ist ein wichtiger Indikator zur Bewertung der Rentabilität eines Unternehmens. Höhere operative Margen sind in der Regel besser, da sie zeigen, dass ein Unternehmen seine Produkte oder Dienstleistungen mit deutlichem Gewinn über den Produktionskosten verkauft. Die operative Marge wird berechnet, indem der Gewinn des Unternehmens durch seinen Umsatz geteilt wird.